Please turn JavaScript on
Biotech Investments icon

Biotech Investments

Receive updates from Biotech Investments for free, starting right now.

We can deliver them by email, via your phone or you can read them from a personalised news page on follow.it.

This way you won't miss any new article from Biotech Investments. Unsubscribe at any time.

Site title: Biotech Investments – Independent Medical Rating Agency for Biotech and Pharmaceutical Assets. Purpose-built for Investors and Industry Partners.

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  6.03 / day

Message History

Douglas AG

Douglas AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

01.05.2026 / 18:50 CET/CEST

Dissemination of a Voting Rights Announcement transmitted by


Read full story

Douglas AG

/ Key word(s): Interim Report/Interim Report

DOUGLAS Group grows sales in Q2 and updates full-year guidance on adjusted EBITDA

30.04.2026 / 19:00 CET/CEST

The issuer is solely responsible for the content of this announcement.

Q2 2025/26 Trading Statement

DOUGLAS Group grows sales in Q2 and updates ful...


Read full story

 

Basel, Switzerland. April 30th 2026, 19.00 CEST.

BioVersys AG (SIX: BIOV), a multi-asset, clin...


Read full story

Gerresheimer AG

Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

30.04.2026 / 18:41 CET/CEST

Dissemination of a Voting Rights Announcement transmitted by


Read full story

Gerresheimer AG

Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

30.04.2026 / 18:38 CET/CEST

Dissemination of a Voting Rights Announcement transmitted by


Read full story